ASTH vs ELV
ASTH: Astrana Health is a physician-centric, technology-enabled platform that manages care and operations for value-based healthcare providers serving Medicare and Medicaid patients. ELV: Elevance Health is a diversified health insurance and services giant that uses its national scale and local Blue Cross Blue Shield presence to manage whole-health needs across insurance benefits and specialized clinical services.
Side-by-side fundamentals
| Metric | ASTH | ELV | Edge |
|---|---|---|---|
| Price as of 2026-10-20 close | $38.58 | $440.18 | |
| Market cap | $2.2B | $95.5B | |
| P/E as of 2026-10-20 | 47.05 | 19.47 | ELV lower |
| PEG as of 2026-10-20, 3-year EPS CAGR to FY2025 | n/a | 15.44 | |
| Net margin FY2025, SEC XBRL | +0.7% | +2.8% | ELV higher |
| Operating margin FY2025, SEC XBRL | +2.5% | +3.6% | ELV higher |
| ROE FY2025, SEC XBRL | +2.8% | +12.9% | ELV higher |
| ROA FY2025, SEC XBRL | +1.0% | +4.7% | ELV higher |
| Debt / equity filed borrowings, leases excl., balance sheet 2026-06-30 | 1.13 | 0.69 | ELV lower |
| Revenue growth (YoY) FY2025, SEC XBRL | +56.4% | +12.5% | ASTH higher |
| Revenue CAGR (3y) SEC XBRL | +40.6% | +8.3% | ASTH higher |
| Dividend yield as of 2026-09-03 | n/a | +1.7% | |
| Dividend streak (yrs) SEC XBRL | n/a | 13 | |
| Beta as of 2026-09-03 | 0.64 | 0.22 | |
| 1-year return as of 2026-10-20 close | +16.9% | +24.3% | ELV higher |
Fundamentals: SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-03 for the rest. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-10-20.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.